All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

278

Reset

278 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • NXC736Phase 21 trial

    NEXTGEN Bioscience · Alopecia Areata

  • OD-07656Phase 21 trial

    Odyssey Therapeutics, Inc. · Ulcerative Colitis (UC), UC - Ulcerative Colitis

  • OLX72021Phase 21 trial

    Olix Pharmaceuticals, Inc. · Androgenetic Alopecia (AGA)

  • PALI-2108Phase 21 trial

    Palisade Bio · Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis

  • PDFE-2304Phase 21 trial

    PDFE Pharma Innovations FZCO · Alopecia, Androgenetic, Baldness, Androgenetic Alopecia (AGA)

  • PF-07264660Phase 21 trial

    Pfizer · Atopic Dermatitis

  • PF-08049820Phase 21 trial

    Pfizer · Atopic Dermatitis, Eczema, Atopic

  • PF-08154225Phase 21 trial

    Pfizer · Systemic Lupus Erythematosus, Rheumatoid Arthritis, Idiopathic Inflammatory Myositis

  • PL8177Active study medicationPhase 21 trial

    Palatin Technologies, Inc · Ulcerative Colitis, Ulcerative Colitis Acute, Ulcerative

  • PTC844Phase 21 trial

    PTC Therapeutics · Rheumatoid Arthritis

  • PTT-621Phase 21 trial

    Pyrotech Therapeutics, Inc. · Ulcerative Colitis (UC)

  • QEL-005Phase 21 trial

    Quell Therapeutics Limited · Diffuse Cutaneous Systemic Sclerosis, Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc)

  • RavagalimabPhase 21 trial

    AbbVie · Rheumatoid Arthritis

  • RO7837195Phase 21 trial

    Roche (Genentech) · Ulcerative Colitis

  • RSLV-132Phase 21 trial

    Resolve Therapeutics · Primary Sjögren Syndrome

  • SAR441566Phase 21 trial

    Sanofi · Rheumatoid Arthritis

  • SAR445399Phase 21 trial

    Sanofi · Hidradenitis Suppurativa

  • SCT650CPhase 21 trial

    Sinocelltech Ltd. · Hidradenitis Suppurativa (HS)

  • SHR-3045Phase 21 trial

    Guangdong Hengrui Pharmaceutical Co., Ltd · Moderate to Severe Active Rheumatoid Arthritis

  • SIM0278Phase 21 trial

    Jiangsu Simcere Pharmaceutical Co., Ltd. · Atopic Dermatitis (AD)

  • STMC-103HPhase 21 trial

    Siolta Therapeutics, Inc. · Atopic Dermatitis, Type 1 Hypersensitivity

  • TAVO101Phase 21 trial

    Tavotek Biotherapeutics · Atopic Dermatitis

  • TRIV-509Phase 21 trial

    Triveni Bio · Atopic Dermatitis

  • TRIV-573Phase 21 trial

    Triveni Bio · Atopic Dermatitis

  • TRX103Phase 21 trial

    Tr1X, Inc. · Crohns Disease

  • UCB1381Phase 21 trial

    UCB · Atopic Dermatitis

  • XmAb942Phase 21 trial

    Xencor, Inc. · Ulcerative Colitis (UC)

  • YR001Phase 21 trial

    Hangzhou Yirui Pharmaceutical Technology Co., Ltd · Atopic Dermatitis

NewerPage 6 of 6

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.